[1]Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, et al.Geog-raphy of HFE C282Y and H63D mutation[J].Genet Test, 2000, 4:183-98.
|
[2]Deicher R, H rl WH.Newinsights into the regulation of iron homeo-stasis[J].Eur J Cli Investigation, 2006, 36:301-309.
|
[3]付丽娟, 段相林, 钱忠明, 等.铁代谢与铁调素hepcidin[J].生理科学进展, 2005, 36 (3) :233-236.
|
[4]Massimo F.Hereditary Iron Overload:Update on Pathophysiology, Diagnosis, and Treatment[J].Am J Hematology, 2006, 81:202-209.
|
[5]Andrews NC.Disorders of iron metabolism[J].N Engl J Med, 1999, 341 (26) :1986-1995.
|
[6]McKie AT, Marciani P, Rolfs A, et al.Anovel duodenal iron-reg-ulated transporter, IREG1, implicated in the basolateral transfer of i-ron to the circulation[J].Mol Cell, 2000, 5:299-309.
|
[7]Donovan A, Brownlie A, Zhou H, et al.Positional cloning of ze-brafish ferroportinⅠidentifies a conserved vertebrate iron exporter[J].Nature, 2000, 403:776-781.
|
[8]Wallace DF, Clark RM, Harley HAJ, et al.Autosomal dominant i-ron overload due to a novel mutation of ferroportinl associated with parenchymal iron loadingand cirrhosis[J].J Hepatol, 2004, 40:710-713.
|
[9]Elizabeta N.Ferroportin mutations:a tale of two phenotypes[J].Blood, 2005, 105:3763-3764.
|
[10]Pietrangelo A.The ferroportin disease[J].Blood Cells Mol Dis, 2004, 32:131-138.
|
[1] | Tian TIAN, Wenwei HU, Xue LI, Jie WU, Dan ZHANG, Changzheng LI. Association between thyroxine level and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2357-2363. doi: 10.3969/j.issn.1001-5256.2021.10.020 |
[2] | Zhao YanJuan, Ye ChunYan, Song XiaoDan. The change in serum thyroid hormone levels in acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(2): 161-162+165. |
[4] | Zhou WenHong, Ying Hao. Analysis of the factors influencing the prognosis of chronic severe hepatitis B[J]. Journal of Clinical Hepatology, 2007, 23(1): 26-27. |
[6] | Liu HuiYuan, Shi YuMing, Li JianPing. Pulmonary infection and its risk factors in the patients with severe viral hepatitis.[J]. Journal of Clinical Hepatology, 2003, 19(6): 347-348. |
[8] | Ding HuiGuo, Gao GuiJu, Chen Tao, Jin Rui. Prognosis of Severe Types of Virous Hepatitis: Study on Mutiple Risk Factors.[J]. Journal of Clinical Hepatology, 2002, 18(5): 297-299. |
[11] | Chen RuiLie, Li JiTing, Liu Min, Fang ShaoPeng. Detection of serum β2 -microglobulin in patients with grave hepatitis and its clinical significance[J]. Journal of Clinical Hepatology, 2002, 18(5): 284-285. |
[12] | Mao JunLing, Chen YuBo, Xia DongMing, Zhang YanHua. Clinical significance of serumthyroxine determination in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2001, 17(2): 101-102. |
[13] | Wei Ni, Song Jun, Wang Qin, Yang YueHua, Su ShiXiang, Hou YongSheng. Relationship between levels of partial plasmatic hormones and clinical manifestation in patients with viral hepatitis.[J]. Journal of Clinical Hepatology, 2000, 16(4): 231-233. |